Updfasp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2025-06-30
Share capital
20,000.00 PLN
Registered address
Rondo Ignacego Daszyńskiego 1, 00-843 Warszawa, Poland
Electronic delivery address
AE:PL-58426-27127-EAEIJ-18
Financials
From the notes
| Loans and borrowings | $80,684 |
Filing timeliness
The financial statement for 2025 was filed on time.
- 202510/07/2026
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 0.09MedianUSD 152.85kAverageUSD 4.86m
Net profit
This companyUSD -5.07kMedianUSD -228.23AverageUSD 317.06k
Operating costs
This companyUSD 4.36kMedianUSD 187.91kAverageUSD 4.67m
Assets
This companyUSD 94.23kMedianUSD 278.35kAverageUSD 8.47m
Industry
Authorized Representatives
Jan Szczerbaniewicz – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Błażej Stanisław Szczerbaniewiczage 55 | 330 | $4,457.05 | 82.5% |
| 70 | $945.43 | 17.5% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 10, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $53,733$53,733 | Podkarpackie Centrum Innowacji sp. z o.o. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| Codeit4us Rndsp. z o.o. | $152,435.96 | codeit4us.com | ||
| VB IdeaP.S.A. | $44,631.63 | vbidea.pl | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| Bio2materialssp. z o.o. | $14,121.59 | bio2materials.com | ||
| Nanostalsp. z o.o. | $8,607.48 | nanostal.com | ||
| IncellvuS.A. | $6,985.93 | incellvu.pl | ||
| NanotheaS.A. | $115.78 | nanothea.com | ||
| MolecureS.A. | $10.77 | molecure.com |
FAQ
The main business activity of Updfa focuses on research and experimental development in natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on June 30, 2025.
The headquarters is located at: Rondo Ignacego Daszyńskiego 1, 00-843 Warszawa.
The share capital of the company is PLN 20,000 (approx. $5,402).
Last updated: 2026-10-04
